Northern Light Venture Capital
北极光创投
Northern Light Venture Capital (北极光创投) is a China-based venture capital firm that shows up in elsewhere's corpus mostly as a co-investor on other firms' deals rather than as a profiled subject. Its recorded activity clusters around 2019–2022: it joined the $24.5M Series A of memory-infrastructure startup MemVerge in April 2019 alongside Gaorong Capital and Lightspeed, then followed on in MemVerge's 2020 strategic round ; it backed Source Code Capital portfolio company Nutshell Therapeutics from the $20M Series A in 2021 onward, adding more in the $40M A+ round in March 2022 ; and in 2022 it took follow-on stakes in metaverse plays — Xmov's $130M round and Sequoia-led $36.8M Series B in UGC platform BUD . On the people side, partner 张朋 appeared on Cyzone's 40 Under 40 investors list, per a 2022 piece . Beyond that, elsewhere's corpus doesn't contain a dedicated profile of the firm — no founding history, fund size, or strategy write-up — so the picture above is assembled from its deal-by-deal appearances.
AI-generated — may contain errors, please verify.
Coverage
Inno Pharmaceuticals Completes Nearly RMB 800 Million Series D Funding to Accelerate Global Multicenter Clinical Development of Precision Targeted Drugs
The company has pioneered a proprietary active-targeting liposomal drug delivery platform, underpinning an innovative drug pipeline that spans multiple serious disease areas, including cardiovascular and cerebrovascular diseases and glioblastoma.
Controllable nuclear fusion high-temperature superconducting magnet company "ChaoCi XinNeng" raises hundreds of millions of yuan in funding, led by Gaorong Ventures
Advancing controlled nuclear fusion magnets from laboratory R&D toward engineering-scale manufacturing.
Andon Therapeutics Raises Over 400 Million Yuan in Series C Funding to Accelerate Phase III Clinical Trials for Revolutionary Pan-Anemia Drug
Focused on R&D of novel drugs for kidney diseases, pan-anemia conditions, and cancer.
Beware of Fake VC Scams
"Private funds raise capital only from specific qualified investors who meet certain criteria." Qiming Venture Partners reminds all investors and entrepreneurs to stay vigilant, verify authenticity, and avoid financial losses.
We Analyzed 1,000 LP Commitments and Found 30 Hidden Top Family Offices
They are also a microcosm of China's commercial evolution.
Energy storage batteries, chips, and other frontier sectors land funding; smart manufacturing leads the charge overseas | Rongbao · September
September milestone.
Simo Microelectronics Completes Series A Funding, Focuses on High-Performance Analog Signal Chain Chip Design
A bridge between the analog and digital worlds.
On the first day of August, we spoke with 23 investors about "confidence."
And, what are the things that are hard but right, and what are the things that are hard but wrong.
MaHui Entrepreneurs | Little Giant XSKY, the "Chongming Bird Initiative" Innovating to Transform an Ancient Industry
The only way to escape the rat race is to stay one step ahead of everyone else.
MaHui | Source Code Capital's Xingchen Zhang Named to Cyzone's 40 Under 40 Investors List
"Finding tech founders full of conviction"
Code Moment | Metaverse UGC Platform "BUD" Closes $36.8 Million Series B Round, Existing Shareholder Source Code Capital Follows On
A New Generation of 3D UGC Social Platforms
Spring Comes Quietly to Guomao
For China's investment industry at this moment, the eerily quiet Guomao feels like a metaphor.
5Y News | Xmov Raises $130 Million to Build Metaverse Infrastructure
Achieving scale, interactivity, and intelligence in metaverse content.
Source Code Capital Portfolio | Nutshell Therapeutics Announces $40 Million Series A+ Round, Existing Shareholder Source Code Capital Continues to Increase Stake
Advance the conformation-based drug discovery platform and innovative pipeline across all fronts
Gaorong Monthly · December | Gaorong Ventures and Its Frontier Tech / Consumer / Healthcare / Enterprise Service Portfolio Companies Win Multiple Annual Awards
Its technological and innovative capabilities have won recognition.
Hangzhou Andao Pharma Closes $50 Million Series B to Advance Drug Development for Kidney Disease and Cancer
Addressing the enormous unmet clinical needs in nephrology and oncology.
Source Code Capital portfolio company "TenaFe" announces $58 million Series B funding round, with existing investor Source Code Capital continuing to increase its stake
Provides end-to-end solid-state drive (SSD) controller solutions, with its chip products approaching mass production.
As Fierce as August | 5Y News Monthly
The big news from last month.
Xiaoice Closes Series A Funding Round, Li Di: AI Beings Will Be Everywhere in the Future | 5Y News
Unveiled super-natural speech synthesis technology — AI now comes infinitely closer to the sound of a real human voice.
Allosteric drug discovery company Nutshell Therapeutics has raised $20 million in a Series A round led by Source Code Capital.
Currently the only platform-type allosteric drug discovery company in China driven by computational methods
Internet Insurance Tech Platform Yuanbao Inc. Closes Nearly RMB 1 Billion Series C Led by Source Code Capital
It has accumulated millions of paying users, covering more than 90% of domestic regions.
MemVerge Secures $19 Million Strategic Investment to Accelerate the "Big Memory Computing" Era
Intel, Cisco, NetApp, and SK hynix — industry leaders — have joined forces to invest, spearheading the big memory revolution.
MemVerge Closes $24.5 Million Series A, Unveils World's First Memory-Converged System
A new data infrastructure that eliminates the boundary between memory and storage.
Shima Raises 300 Million RMB in Series C to Improve Mobility for 800 Million Rural Residents | FreeS Fund News
Constantly pushing boundaries.
Why Is the Pay Gap Between '80s and '90s AI Talent Only 15%? | *2017 Early-Stage Enterprise Compensation Survey Report*
The salary secrets of 19,014 positions across 152 companies.
How Should Startups Design a Compensation System? Here's a Chance to Get the *2017 Early-Stage Enterprise Compensation Survey Report*
Manage the "people" and the "money."
